Vivimed Labs Ltd. gets 87.63% of its revenue from
Pharmaceuticals
Vivimed Labs Limited
Market Cap:
₹146 Cr.
Percentage Revenue:
87.63%
Pharmaceuticals
Zim Laboratories Limited
Market Cap:
₹151 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Zim Laboratories Limited
Market Cap:
₹151 Cr.
Percentage Revenue:
50%
Pharmaceuticals
Fredun Pharmaceuticals Limited
Market Cap:
₹160 Cr.
Percentage Revenue:
%
Pharmaceuticals
Fredun Pharmaceuticals Limited
Market Cap:
₹160 Cr.
Percentage Revenue:
98%
Pharmaceuticals
Dr Agarwals Eye Hospital Ltd.
Market Cap:
₹124 Cr.
Percentage Revenue:
7.17%
Pharmaceuticals
Ambalal Sarabhai Enterprises Limited
Market Cap:
₹179 Cr.
Percentage Revenue:
%
Pharmaceuticals
Ambalal Sarabhai Enterprises Limited
Market Cap:
₹179 Cr.
Percentage Revenue:
50.11%
Pharmaceuticals
Coral Lab
Market Cap:
₹107 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Bal Pharma Limited
Market Cap:
₹80 Cr.
Percentage Revenue:
%
Pharmaceuticals
Everest Organics Limited
Market Cap:
₹216 Cr.
Percentage Revenue:
%
Pharmaceuticals
Bharat Parenterals Limited
Market Cap:
₹226 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Himalaya Food lnternational Ltd.
Market Cap:
₹64 Cr.
Percentage Revenue:
%
Pharmaceuticals
Albert David Limited
Market Cap:
₹256 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Ind-Swift Limited
Market Cap:
₹25 Cr.
Percentage Revenue:
%
Pharmaceuticals
Ind-Swift Limited
Market Cap:
₹25 Cr.
Percentage Revenue:
%
Pharmaceuticals
Themis Medicare Limited
Market Cap:
₹315 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Zota Healthcare Limited
Market Cap:
₹403 Cr.
Percentage Revenue:
%
Pharmaceuticals
Zota Healthcare Limited
Market Cap:
₹403 Cr.
Percentage Revenue:
72.41%
Pharmaceuticals
Ind-Swift Laboratories Limited
Market Cap:
₹442 Cr.
Percentage Revenue:
%
Pharmaceuticals
Nectar Lifesciences Limited
Market Cap:
₹500 Cr.
Percentage Revenue:
%
Pharmaceuticals
Nectar Lifesciences Limited
Market Cap:
₹500 Cr.
Percentage Revenue:
99.98%
Pharmaceuticals
Medicamen Biotech Limited
Market Cap:
₹547 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Anuh Pharma Limited
Market Cap:
₹657 Cr.
Percentage Revenue:
%
Pharmaceuticals
Anuh Pharma Limited
Market Cap:
₹657 Cr.
Percentage Revenue:
%
Pharmaceuticals
Anuh Pharma Limited
Market Cap:
₹657 Cr.
Percentage Revenue:
%
Pharmaceuticals
Anuh Pharma Limited
Market Cap:
₹657 Cr.
Percentage Revenue:
%
Pharmaceuticals
Anuh Pharma Limited
Market Cap:
₹657 Cr.
Percentage Revenue:
%
Pharmaceuticals
Anuh Pharma Limited
Market Cap:
₹657 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Wendt (India) Limited
Market Cap:
₹671 Cr.
Percentage Revenue:
%
Pharmaceuticals
Bajaj Healthcare Limited
Market Cap:
₹695 Cr.
Percentage Revenue:
%
Pharmaceuticals
Bajaj Healthcare Limited
Market Cap:
₹695 Cr.
Percentage Revenue:
97.67%
Pharmaceuticals
NGL Fine-Chem Limited
Market Cap:
₹753 Cr.
Percentage Revenue:
%
Pharmaceuticals
TTK Healthcare Limited
Market Cap:
₹803 Cr.
Percentage Revenue:
%
Pharmaceuticals
TTK Healthcare Limited
Market Cap:
₹803 Cr.
Percentage Revenue:
34.47%
Pharmaceuticals
TTK Healthcare Limited
Market Cap:
₹803 Cr.
Percentage Revenue:
18.55%
Pharmaceuticals
TTK Healthcare Limited
Market Cap:
₹803 Cr.
Percentage Revenue:
19.5%
Pharmaceuticals
Gufic Biosciences Limited
Market Cap:
₹974 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Morepen Laboratories Limited
Market Cap:
₹1,356 Cr.
Percentage Revenue:
%
Pharmaceuticals
Morepen Laboratories Limited
Market Cap:
₹1,356 Cr.
Percentage Revenue:
%
Pharmaceuticals
Morepen Laboratories Limited
Market Cap:
₹1,356 Cr.
Percentage Revenue:
%
Pharmaceuticals
Morepen Laboratories Limited
Market Cap:
₹1,356 Cr.
Percentage Revenue:
%
Pharmaceuticals
Hester Biosciences Ltd
Market Cap:
₹1,435 Cr.
Percentage Revenue:
%
Pharmaceuticals
Neuland Laboratories Limited
Market Cap:
₹1,567 Cr.
Percentage Revenue:
%
Pharmaceuticals
Neuland Laboratories Limited
Market Cap:
₹1,567 Cr.
Percentage Revenue:
69%
Pharmaceuticals
Amrutanjan Health Care Limited
Market Cap:
₹1,578 Cr.
Percentage Revenue:
%
Pharmaceuticals
Novartis India Ltd
Market Cap:
₹1,683 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Healthcare Global Enterprises Limited
Market Cap:
₹2,006 Cr.
Percentage Revenue:
7.62%
Pharmaceuticals
Unichem Laboratories Limited
Market Cap:
₹2,013 Cr.
Percentage Revenue:
%
Pharmaceuticals
Unichem Laboratories Limited
Market Cap:
₹2,013 Cr.
Percentage Revenue:
%
Pharmaceuticals
Unichem Laboratories Limited
Market Cap:
₹2,013 Cr.
Percentage Revenue:
%
Pharmaceuticals
Unichem Laboratories Limited
Market Cap:
₹2,013 Cr.
Percentage Revenue:
%
Pharmaceuticals
Unichem Laboratories Limited
Market Cap:
₹2,013 Cr.
Percentage Revenue:
%
Pharmaceuticals
Unichem Laboratories Limited
Market Cap:
₹2,013 Cr.
Percentage Revenue:
%
Pharmaceuticals
Unichem Laboratories Limited
Market Cap:
₹2,013 Cr.
Percentage Revenue:
10%
Pharmaceuticals
Hikal Limited
Market Cap:
₹2,123 Cr.
Percentage Revenue:
%
Pharmaceuticals
Hikal Limited
Market Cap:
₹2,123 Cr.
Percentage Revenue:
%
Pharmaceuticals
Hikal Limited
Market Cap:
₹2,123 Cr.
Percentage Revenue:
59.08%
Pharmaceuticals
Claris Lifesciences Limited
Market Cap:
₹2,164 Cr.
Percentage Revenue:
%
Pharmaceuticals
Claris Lifesciences Limited
Market Cap:
₹2,164 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Fresenius Kabi Oncology Ltd.
Market Cap:
₹2,255 Cr.
Percentage Revenue:
%
Pharmaceuticals
Dishman Carbogen Amics Limited
Market Cap:
₹2,319 Cr.
Percentage Revenue:
60.5%
Pharmaceuticals
Dishman Carbogen Amics Limited
Market Cap:
₹2,319 Cr.
Percentage Revenue:
58%
Pharmaceuticals
Dishman Carbogen Amics Limited
Market Cap:
₹2,319 Cr.
Percentage Revenue:
21.82%
Pharmaceuticals
Alembic Limited
Market Cap:
₹2,645 Cr.
Percentage Revenue:
%
Pharmaceuticals
Indoco Remedies Limited
Market Cap:
₹2,823 Cr.
Percentage Revenue:
%
Pharmaceuticals
Indoco Remedies Limited
Market Cap:
₹2,823 Cr.
Percentage Revenue:
%
Pharmaceuticals
Indoco Remedies Limited
Market Cap:
₹2,823 Cr.
Percentage Revenue:
%
Pharmaceuticals
Indoco Remedies Limited
Market Cap:
₹2,823 Cr.
Percentage Revenue:
%
Pharmaceuticals
Indoco Remedies Limited
Market Cap:
₹2,823 Cr.
Percentage Revenue:
%
Pharmaceuticals
Indoco Remedies Limited
Market Cap:
₹2,823 Cr.
Percentage Revenue:
%
Pharmaceuticals
Indoco Remedies Limited
Market Cap:
₹2,823 Cr.
Percentage Revenue:
%
Pharmaceuticals
Indoco Remedies Limited
Market Cap:
₹2,823 Cr.
Percentage Revenue:
%
Pharmaceuticals
Indoco Remedies Limited
Market Cap:
₹2,823 Cr.
Percentage Revenue:
%
Pharmaceuticals
Indoco Remedies Limited
Market Cap:
₹2,823 Cr.
Percentage Revenue:
%
Pharmaceuticals
Indoco Remedies Limited
Market Cap:
₹2,823 Cr.
Percentage Revenue:
%
Pharmaceuticals
Indoco Remedies Limited
Market Cap:
₹2,823 Cr.
Percentage Revenue:
%
Pharmaceuticals
Shilpa Medicare Limited
Market Cap:
₹3,571 Cr.
Percentage Revenue:
67.32%
Pharmaceuticals
Shilpa Medicare Limited
Market Cap:
₹3,571 Cr.
Percentage Revenue:
97.5%
Pharmaceuticals
Caplin Point Laboratories Limited
Market Cap:
₹3,684 Cr.
Percentage Revenue:
%
Pharmaceuticals
IOL Chemicals and Pharmaceuticals Limited
Market Cap:
₹4,211 Cr.
Percentage Revenue:
%
Pharmaceuticals
Sun Pharma Advanced Research Company Limited
Market Cap:
₹5,014 Cr.
Percentage Revenue:
%
Pharmaceuticals
Thyrocare Technologies Limited
Market Cap:
₹5,046 Cr.
Percentage Revenue:
0.54%
Pharmaceuticals
Sequent Scientific Limited
Market Cap:
₹5,248 Cr.
Percentage Revenue:
%
Pharmaceuticals
Sequent Scientific Limited
Market Cap:
₹5,248 Cr.
Percentage Revenue:
%
Pharmaceuticals
FDC Limited
Market Cap:
₹5,558 Cr.
Percentage Revenue:
4.96%
Pharmaceuticals
Wockhardt Limited
Market Cap:
₹5,903 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Aarti Drugs Limited
Market Cap:
₹6,594 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Strides Pharma Science Limited
Market Cap:
₹8,143 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
%
Pharmaceuticals
Eris Lifesciences
Market Cap:
₹8,480 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Granules India Limited
Market Cap:
₹8,816 Cr.
Percentage Revenue:
%
Pharmaceuticals
Granules India Limited
Market Cap:
₹8,816 Cr.
Percentage Revenue:
52%
Pharmaceuticals
Narayana Hrudayalaya Ltd
Market Cap:
₹9,570 Cr.
Percentage Revenue:
4.1%
Pharmaceuticals
AstraZeneca Pharma India Limited
Market Cap:
₹10,557 Cr.
Percentage Revenue:
%
Pharmaceuticals
Merck Limited
Market Cap:
₹11,290 Cr.
Percentage Revenue:
%
Pharmaceuticals
Fortis Healthcare Limited
Market Cap:
₹12,532 Cr.
Percentage Revenue:
78.05%
Pharmaceuticals
Glenmark Pharmaceuticals Limited
Market Cap:
₹14,454 Cr.
Percentage Revenue:
56.68%
Pharmaceuticals
Glenmark Pharmaceuticals Limited
Market Cap:
₹14,454 Cr.
Percentage Revenue:
41.44%
Pharmaceuticals
Ajanta Pharma Limited
Market Cap:
₹15,117 Cr.
Percentage Revenue:
%
Pharmaceuticals
Ajanta Pharma Limited
Market Cap:
₹15,117 Cr.
Percentage Revenue:
100%
Pharmaceuticals
Ajanta Pharma Limited
Market Cap:
₹15,117 Cr.
Percentage Revenue:
%
Pharmaceuticals
Jubilant Life Sciences Limited
Market Cap:
₹15,540 Cr.
Percentage Revenue:
%
Pharmaceuticals
Jubilant Life Sciences Limited
Market Cap:
₹15,540 Cr.
Percentage Revenue:
87.2%
Pharmaceuticals
Jubilant Life Sciences Limited
Market Cap:
₹15,540 Cr.
Percentage Revenue:
38.91%
Pharmaceuticals
Jubilant Life Sciences Limited
Market Cap:
₹15,540 Cr.
Percentage Revenue:
58.44%
Pharmaceuticals
Jubilant Life Sciences Limited
Market Cap:
₹15,540 Cr.
Percentage Revenue:
27.19%
Pharmaceuticals
Natco Pharma Limited
Market Cap:
₹16,712 Cr.
Percentage Revenue:
%
Pharmaceuticals
Natco Pharma Limited
Market Cap:
₹16,712 Cr.
Percentage Revenue:
%
Pharmaceuticals
Natco Pharma Limited
Market Cap:
₹16,712 Cr.
Percentage Revenue:
15.22%
Pharmaceuticals
Sanofi India Limited
Market Cap:
₹19,199 Cr.
Percentage Revenue:
%
Pharmaceuticals
Laurus Labs
Market Cap:
₹19,841 Cr.
Percentage Revenue:
%
Pharmaceuticals
Alembic Pharmaceuticals Limited
Market Cap:
₹21,384 Cr.
Percentage Revenue:
%
Pharmaceuticals
Pfizer Limited
Market Cap:
₹23,394 Cr.
Percentage Revenue:
%
Pharmaceuticals
Pfizer Limited
Market Cap:
₹23,394 Cr.
Percentage Revenue:
%
Pharmaceuticals
Pfizer Limited
Market Cap:
₹23,394 Cr.
Percentage Revenue:
%
Pharmaceuticals
Pfizer Limited
Market Cap:
₹23,394 Cr.
Percentage Revenue:
%
Pharmaceuticals
Pfizer Limited
Market Cap:
₹23,394 Cr.
Percentage Revenue:
%
Pharmaceuticals
Pfizer Limited
Market Cap:
₹23,394 Cr.
Percentage Revenue:
%
Pharmaceuticals
Pfizer Limited
Market Cap:
₹23,394 Cr.
Percentage Revenue:
%
Pharmaceuticals
Pfizer Limited
Market Cap:
₹23,394 Cr.
Percentage Revenue:
%
Pharmaceuticals
Pfizer Limited
Market Cap:
₹23,394 Cr.
Percentage Revenue:
%
Pharmaceuticals
Pfizer Limited
Market Cap:
₹23,394 Cr.
Percentage Revenue:
100%
Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited
Market Cap:
₹25,680 Cr.
Percentage Revenue:
%
Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited
Market Cap:
₹25,680 Cr.
Percentage Revenue:
%
Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited
Market Cap:
₹25,680 Cr.
Percentage Revenue:
%
Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited
Market Cap:
₹25,680 Cr.
Percentage Revenue:
%
Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited
Market Cap:
₹25,680 Cr.
Percentage Revenue:
%
Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited
Market Cap:
₹25,680 Cr.
Percentage Revenue:
%
Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited
Market Cap:
₹25,680 Cr.
Percentage Revenue:
%
Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited
Market Cap:
₹25,680 Cr.
Percentage Revenue:
%
Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited
Market Cap:
₹25,680 Cr.
Percentage Revenue:
%
Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited
Market Cap:
₹25,680 Cr.
Percentage Revenue:
%
Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited
Market Cap:
₹25,680 Cr.
Percentage Revenue:
%
Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited
Market Cap:
₹25,680 Cr.
Percentage Revenue:
100%
Pharmaceuticals
IPCA Laboratories Limited
Market Cap:
₹26,784 Cr.
Percentage Revenue:
%
Pharmaceuticals
IPCA Laboratories Limited
Market Cap:
₹26,784 Cr.
Percentage Revenue:
33.5%
Pharmaceuticals
Abbott India Limited
Market Cap:
₹31,869 Cr.
Percentage Revenue:
%
Pharmaceuticals
Abbott India Limited
Market Cap:
₹31,869 Cr.
Percentage Revenue:
%
Pharmaceuticals
Abbott India Limited
Market Cap:
₹31,869 Cr.
Percentage Revenue:
%
Pharmaceuticals
Abbott India Limited
Market Cap:
₹31,869 Cr.
Percentage Revenue:
%
Pharmaceuticals
Abbott India Limited
Market Cap:
₹31,869 Cr.
Percentage Revenue:
%
Pharmaceuticals
Abbott India Limited
Market Cap:
₹31,869 Cr.
Percentage Revenue:
%
Pharmaceuticals
Abbott India Limited
Market Cap:
₹31,869 Cr.
Percentage Revenue:
%
Pharmaceuticals
Abbott India Limited
Market Cap:
₹31,869 Cr.
Percentage Revenue:
%
Pharmaceuticals
Abbott India Limited
Market Cap:
₹31,869 Cr.
Percentage Revenue:
%
Pharmaceuticals
Piramal Enterprises Limited
Market Cap:
₹36,638 Cr.
Percentage Revenue:
36.22%
Pharmaceuticals
Alkem Laboratories Limited
Market Cap:
₹37,099 Cr.
Percentage Revenue:
%
Pharmaceuticals
Alkem Laboratories Limited
Market Cap:
₹37,099 Cr.
Percentage Revenue:
93.72%
Pharmaceuticals
Torrent Pharmaceuticals Limited
Market Cap:
₹45,912 Cr.
Percentage Revenue:
%
Pharmaceuticals
Torrent Pharmaceuticals Limited
Market Cap:
₹45,912 Cr.
Percentage Revenue:
%
Pharmaceuticals
Torrent Pharmaceuticals Limited
Market Cap:
₹45,912 Cr.
Percentage Revenue:
%
Pharmaceuticals
Torrent Pharmaceuticals Limited
Market Cap:
₹45,912 Cr.
Percentage Revenue:
%
Pharmaceuticals
Lupin Limited
Market Cap:
₹49,576 Cr.
Percentage Revenue:
%
Pharmaceuticals
Lupin Limited
Market Cap:
₹49,576 Cr.
Percentage Revenue:
%
Pharmaceuticals
Cadila Healthcare Limited
Market Cap:
₹49,959 Cr.
Percentage Revenue:
%
Pharmaceuticals
Cadila Healthcare Limited
Market Cap:
₹49,959 Cr.
Percentage Revenue:
%
Pharmaceuticals
Biocon Limited
Market Cap:
₹54,810 Cr.
Percentage Revenue:
%
Pharmaceuticals
Biocon Limited
Market Cap:
₹54,810 Cr.
Percentage Revenue:
%
Pharmaceuticals
Biocon Limited
Market Cap:
₹54,810 Cr.
Percentage Revenue:
%
Pharmaceuticals
Biocon Limited
Market Cap:
₹54,810 Cr.
Percentage Revenue:
%
Pharmaceuticals
Biocon Limited
Market Cap:
₹54,810 Cr.
Percentage Revenue:
%
Pharmaceuticals
Aurobindo Pharma Limited
Market Cap:
₹54,861 Cr.
Percentage Revenue:
%
Pharmaceuticals
Aurobindo Pharma Limited
Market Cap:
₹54,861 Cr.
Percentage Revenue:
%
Pharmaceuticals
Cipla Limited
Market Cap:
₹66,416 Cr.
Percentage Revenue:
99%
Pharmaceuticals
Cipla Limited
Market Cap:
₹66,416 Cr.
Percentage Revenue:
%
Pharmaceuticals
Dr. Reddy's Laboratories Limited
Market Cap:
₹86,601 Cr.
Percentage Revenue:
15%
Pharmaceuticals
Dr. Reddy's Laboratories Limited
Market Cap:
₹86,601 Cr.
Percentage Revenue:
%
Pharmaceuticals
Divi's Laboratories Limited
Market Cap:
₹96,702 Cr.
Percentage Revenue:
%
Pharmaceuticals
Sun Pharmaceuticals Industries Limited
Market Cap:
₹144,920 Cr.
Percentage Revenue:
%